🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 653.18 -0.3% NASDAQ 100: 583.98 -0.7% Dow Jones: 461.17 -0.2%

Aqr Capital Management - Q4 2025 13F Filings

AQ

Aqr Capital Management LLC

CIK: 0001167557
Address: Connecticut Greenwich One Greenwich Plaza Suite 130
$190.63 B
Portfolio Value
3562
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 02/17/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. TEAM Atlassian Corporation
+$935.51 M
2. BMY Bristol-Myers Squibb Company
+$881 M
3. NVDA Nvidia Corporation
+$737.12 M
4. CNC Centene Corporation
+$705.47 M
5. AAPL Apple
+$457.11 M

Top Sells

Q4 2025
1. MOH Molina Healthcare
−$437.97 M
2. INTC Intel Corporation
−$321.64 M
3. GM General Motors Company
−$273.96 M
4. DASH Doordash
−$217.26 M
5. INTU Intuit
−$187.54 M

Asset Allocation

Stocks/ETFs
+22.08%
$190.4 B 99.88%
Options
$0 0.00%
Debt
$0 0.00%
Other
+572.92%
$232.73 M 0.12%

Sector Allocation (Stocks)

Aqr Capital Management Q4 2025 Filing Summary

Aqr Capital Management LLC filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 190.63 B reflecting a +22.20% change from the prior quarter, spanning 3,562 assets. The top 10 holdings comprised 11.5% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 222 new positions and 104 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Aqr Capital Management’s Q4 2025 Filing

Aqr Capital Management submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Aqr Capital Management reported a managed portfolio value of 190.63 B, consisting of 16,934 individual positions.

This page displays the raw filing documents. To see which stocks Aqr Capital Management bought or sold during Q4 2025, please visit Aqr Capital Management's Portfolio Analysis page.